TRAVERE THERAPEUTICS INC's ticker is and the CUSIP is 89422GAA5. A total of 22 filers reported holding TRAVERE THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $12,629,691 | +14.4% | 19,393,000 | +11.5% | 0.04% | 0.0% |
| Q1 2024 | $11,035,859 | -13.8% | 17,393,000 | -10.3% | 0.04% | +2.6% |
| Q4 2023 | $12,799,380 | -15.7% | 19,393,000 | -17.1% | 0.04% | -42.6% |
| Q3 2023 | $15,177,378 | -57.5% | 23,393,000 | -47.3% | 0.07% | -61.4% |
| Q2 2023 | $35,708,619 | +17.6% | 44,393,000 | +43.7% | 0.18% | +14.3% |
| Q1 2023 | $30,367,819 | -30.9% | 30,893,000 | -35.7% | 0.15% | -51.9% |
| Q4 2022 | $43,959,345 | +23.2% | 48,043,000 | +37.7% | 0.32% | +48.8% |
| Q3 2022 | $35,685,000 | +13.3% | 34,900,000 | +11.1% | 0.22% | +39.6% |
| Q2 2022 | $31,494,000 | +47.9% | 31,400,000 | +57.0% | 0.15% | +161.0% |
| Q1 2022 | $21,290,000 | – | 20,000,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Context Capital Management, LLC | 60,742 | $39,558,228 | 1.42% |
| SILVERBACK ASSET MANAGEMENT LLC | 15,000,000 | $9,757,805 | 1.20% |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 27,500,000 | $17,724,806 | 1.10% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 33,225,000 | $21,216,488 | 0.68% |
| WOLVERINE ASSET MANAGEMENT LLC | 45,400,000 | $29,409,596 | 0.33% |
| READYSTATE ASSET MANAGEMENT LP | 8,000,000 | $5,210,000 | 0.17% |
| AQR Arbitrage LLC | 9,975,000 | $6,496,219 | 0.17% |
| DeepCurrents Investment Group LLC | 2,000,000 | $1,269,535 | 0.05% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 19,393,000 | $12,629,691 | 0.04% |
| CSS LLC/IL | 1,000,000 | $647,943 | 0.03% |